Vanberra Signal

Atavistik

Curated by Signal

Developer of allosteric therapeutics for precision oncology and rare diseases

Overview

Developer of allosteric therapeutics for precision oncology and rare diseases. The company integrated with proprietary drug discovery platform that enables to unlock novel allosteric binding pockets and rapidly advance structural insights into small molecule therapeutics designt to unlock cryptic allosteric sites across a broad range of target classes.

Key facts

Founded
2021

Business model

Contact

Open roles

2 roles
  • Scientist II/Senior Scientist, Biology

    Cambridge, MA · On-site · Volunteer

  • Senior Manager, HR Operations

    Cambridge, MA · On-site · Volunteer

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of a wearable device for glucose monitoring

    Life Sciences TechnologySan Diego, United States
  • Developer of home blood glucose monitor

    Life Sciences TechnologyFort Lauderdale, United States
  • All-in-one blood glucose monitoring system

    Life Sciences TechnologySan Francisco, United States

About Atavistik

What does Atavistik do?

Developer of allosteric therapeutics for precision oncology and rare diseases.

Where is Atavistik headquartered?

Atavistik is headquartered in Cambridge, United States.

When was Atavistik founded?

Atavistik was founded in 2021.

Which sector is Atavistik in?

Atavistik operates in Life Sciences Technology.

Who are Atavistik's competitors?

Companies similar to Atavistik include Dexcom, Home Diagnostics, and Intuity Medical.

Is Atavistik hiring?

Yes. Atavistik has 2 open roles listed on Vanberra Signal.